Skip to content
← Back to this collection

PUBLICATIONS · 16403813

Prediction of response to imatinib by prospective quantitation of BCR-ABL transcript in late chronic phase chronic myeloid leukemia patients.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Ann Oncol
Publication date
2006 Mar
First author
Martinelli G

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Martinelli G
      type
      Author
    2. name
      Iacobucci I
      type
      Author
    3. name
      Rosti G
      type
      Author
    4. name
      Pane F
      type
      Author
    5. name
      Amabile M
      type
      Author
    6. name
      Castagnetti F
      type
      Author
    7. name
      Cilloni D
      type
      Author
    8. name
      Soverini S
      type
      Author
    9. name
      Testoni N
      type
      Author
    10. name
      Specchia G
      type
      Author
    11. name
      Merante S
      type
      Author
    12. name
      Zaccaria A
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Martinelli G
      type
      Author
    2. name
      Iacobucci I
      type
      Author
    3. name
      Rosti G
      type
      Author
    4. name
      Pane F
      type
      Author
    5. name
      Amabile M
      type
      Author
    6. name
      Castagnetti F
      type
      Author
    7. name
      Cilloni D
      type
      Author
    8. name
      Soverini S
      type
      Author
    9. name
      Testoni N
      type
      Author
    10. name
      Specchia G
      type
      Author
    11. name
      Merante S
      type
      Author
    12. name
      Zaccaria A
      type
      Author
    bibliography ids
    1. nci-bib-00b9310f7cec06be8f175d58
    book metadata
    content sha256
    87b17a592439918ca225d8ecc802705f36c3dbea6f8fe255b114314f58b19ff8
    document type
    citation
    dois
    1. 10.1093/annonc/mdj106
    electronic publication date
    display
    2006 Jan 10
    precision
    day
    year
    2006
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:16403813
    immutable id
    pubmed:16403813@87b17a592439918ca225d8ecc802705f36c3dbea6f8fe255b114314f58b19ff8
    journal
    abbreviation
    Ann Oncol
    issn electronic
    Source null
    issn print
    0923-7534
    issue
    3
    name
    Annals of oncology : official journal of the European Society for Medical Oncology
    nlm unique id
    9007735
    pages
    495-502
    volume
    17
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      16403813
      provenance
      batch id
      a181c30258a88d182e78
      provider
      NCBI PubMed ESummary
      record sha256
      0465027baa84307529d932b742ee9838cb4ca6c4300c258fc359b5dd222ab6cd
      response sha256
      558e0dce453ae424567844b062522ebd1d27363c3312c81dbf6f32a8ff08da24
      retrieved at
      2026-09-09T23:46:03.896343+00:00
      publication date
      display
      2006 Mar
      precision
      month
      year
      2006
      publication types
      1. Journal Article
      2. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/16403813/
      title
      Prediction of response to imatinib by prospective quantitation of BCR-ABL transcript in late chronic phase chronic myeloid leukemia patients.

      Preserved source evidence · Not medical advice